Home LiteratureArticle Details
PMID: 14979907 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review

Microarrays bring new insights into understanding of breast cancer metastasis to bone.

Breast cancer research : BCR ·Vol. 6 ·No. 2 ·2004-00-00 ·Pages 61-4

Welch DR

Abstract

Using a microarray approach, Kang and colleagues identified several genes involved in the generation of breast cancer metastasis in bone and demonstrated their roles in bone colonization in vivo. Their findings and interpretations are reviewed in the context of recent array studies that compared gene expression in primary tumors and metastases. RNA expression array results have already demonstrated value in predicting whether metastases will develop in patients. They have also shown that expression patterns are similar in primary tumors and metastases. The latter data have invited re-examination of long-held notions related to mechanisms of metastasis. While the arrays show promise for improving diagnostic capability in breast cancers, ascribing mechanistic interpretations to correlative data should be done with extreme caution. Kang and colleagues' paper in Cancer Cell elegantly reinforces the concepts that efficiency of the metastatic process is dependent on the coordinated expression of multiple genes and that the expression of metastasis-associated genes is sometimes dependent on the microenvironment in which cells find themselves.

MeSH Terms
Bone Neoplasms/genetics,secondary Breast Neoplasms/genetics,secondary Gene Expression Profiling/methods Gene Expression Regulation, Neoplastic/genetics Genes, Neoplasm/genetics Humans Oligonucleotide Array Sequence Analysis/methods
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Welch Danny R
Department of Pathology, Comprehensive Cancer Center, National Foundation for Cancer Research Center for Metastasis Research, University of Alabama at Birmingham, USA. [email protected]
References (28)
28 references, click to expand
  1. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.
    Int J Cancer. 1998 Aug 12;77(4):640-4 PMID: 9679770
  2. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
    N Engl J Med. 1988 Nov 10;319(19):1239-45 PMID: 2903446
  3. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?
    Cell. 2003 Jun 27;113(7):821-3 PMID: 12837240
  4. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.
    Cancer Res. 1998 Nov 1;58(21):4963-9 PMID: 9810006
  5. The microarray way to tailored cancer treatment.
    Nat Med. 2002 Jan;8(1):13-4 PMID: 11786894
  6. A molecular signature of metastasis in primary solid tumors.
    Nat Genet. 2003 Jan;33(1):49-54 PMID: 12469122
  7. Molecular portraits of human breast tumours.
    Nature. 2000 Aug 17;406(6797):747-52 PMID: 10963602
  8. Gene expression profiling predicts clinical outcome of breast cancer.
    Nature. 2002 Jan 31;415(6871):530-6 PMID: 11823860
  9. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.
    Cancer Res. 2002 Apr 1;62(7):2162-8 PMID: 11929839
  10. A multigenic program mediating breast cancer metastasis to bone.
    Cancer Cell. 2003 Jun;3(6):537-49 PMID: 12842083
  11. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma.
    Cancer Res. 1975 Mar;35(3):512-6 PMID: 1090362
  12. A progression puzzle.
    Nature. 2002 Aug 22;418(6900):823 PMID: 12192390
  13. Evidence for the clonal origin of spontaneous metastases.
    Science. 1982 Jul 23;217(4557):361-3 PMID: 6953592
  14. The distribution of secondary growths in cancer of the breast. 1889.
    Cancer Metastasis Rev. 1989 Aug;8(2):98-101 PMID: 2673568
  15. Metastasis suppressor pathways--an evolving paradigm.
    Cancer Lett. 2003 Jul 30;198(1):1-20 PMID: 12893425
  16. Involvement of chemokine receptors in breast cancer metastasis.
    Nature. 2001 Mar 1;410(6824):50-6 PMID: 11242036
  17. Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population.
    Nat Genet. 2003 May;34(1):23; author reply 25 PMID: 12721548
  18. Genetic background is an important determinant of metastatic potential.
    Nat Genet. 2003 May;34(1):23-4; author reply 25 PMID: 12721549
  19. Mutations of Bacteria from Virus Sensitivity to Virus Resistance.
    Genetics. 1943 Nov;28(6):491-511 PMID: 17247100
  20. Cancer spread and micrometastasis development: quantitative approaches for in vivo models.
    Bioessays. 2002 Oct;24(10):885-93 PMID: 12325121
  21. What defines a useful marker of metastasis in human cancer?
    J Natl Cancer Inst. 1999 Aug 18;91(16):1351-3 PMID: 10451432
  22. Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate.
    Clin Exp Metastasis. 1999;17(7):601-7 PMID: 10845559
  23. Metastatic inefficiency.
    Adv Cancer Res. 1990;54:159-211 PMID: 1688681
  24. A gene-expression signature as a predictor of survival in breast cancer.
    N Engl J Med. 2002 Dec 19;347(25):1999-2009 PMID: 12490681
  25. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
    Cancer Res. 1999 Nov 1;59(21):5483-7 PMID: 10554023
  26. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
    Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74 PMID: 11553815
  27. Road map to metastasis.
    Nat Med. 2003 Aug;9(8):999-1000 PMID: 12894162
  28. Metastasis suppressors alter the signal transduction of cancer cells.
    Nat Rev Cancer. 2003 Jan;3(1):55-63 PMID: 12509767
Article Info
Journal
Breast cancer research : BCR
Abbr.
Breast Cancer Res
ISSN
1465-542X
Published
2004-00-00
Epub
2003-00-30
Pages
61-4
Language
English
Region
England
NLM ID
100927353
PMCID
PMC400646
Subset
IM
Grants
NCI NIH HHS · R01 CA087728 · United States
NCI NIH HHS · P50-CA89019 · United States
NCI NIH HHS · P50 CA089019 · United States
NCI NIH HHS · R01-CA87728 · United States
NCI NIH HHS · CA62168 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]